Sharing data to prevent Alzheimer鈥檚 disease
An open science collection of data from persons at-risk of developing Alzheimer鈥檚 Disease (AD) will help researchers study the pre-symptomatic phase of the disease and accelerate the develop of new therapies that could slow down the disease process.
The project, called PREVENT-AD, stands for Pre-symptomatic Evaluation of Experimental or Novel Treatments for AD, and was performed at The Centre for Studies on Prevention of Alzheimer鈥檚 Disease at the Douglas Mental Health University Institute in Montreal. Between 2011 and 2017 the centre followed 425 people at high risk of AD, collecting a wealth of medical information, including 1,704 MRI scanning sessions, 532 cerebrospinal fluid samples and 1,882 cognitive follow ups.
PREVENT-AD聽is part of the聽Canadian Open Neuroscience Platform (CONP), a partnership of universities across Canada that will store, analyze, and disseminate research data among its members. Alan Evans is the CONP鈥檚 scientific director.
PREVENT-AD research group was created under the leadership of Dr. John Breitner and is now directed by Judes Poirier and co-directed by Sylvia Villeneuve, with collaborators from UU直播 and from Universit茅 de Montr茅al and other leading institutions in the US and Europe.
Read the story in .